CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $908,000 | +114.2% | 61,078 | +257.2% | 0.01% | +100.0% |
| Q1 2019 | $424,000 | -6.6% | 17,100 | -32.4% | 0.00% | -25.0% |
| Q4 2018 | $454,000 | -14.8% | 25,281 | +39.4% | 0.00% | 0.0% |
| Q3 2018 | $533,000 | -25.6% | 18,133 | +15.3% | 0.00% | -20.0% |
| Q2 2018 | $716,000 | -13.8% | 15,733 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $831,000 | – | 15,733 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |